712349-59-2Relevant academic research and scientific papers
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi
Greenbaum, Doron C.,Mackey, Zachary,Hansell, Elizabeth,Doyle, Patricia,Gut, Jiri,Caffrey, Conor R.,Lehrman, Julia,Rosenthal, Philip J.,McKerrow, James H.,Chibale, Kelly
, p. 3212 - 3219 (2004)
We have synthesized a library of thiosemicarbazones and screened them against three parasitic cysteine proteases, cruzain, falcipain-2, and rhodesain, and against the respective parasite sources of these three proteases, Trypanosoma cruzi, Plasmodium falciparum, and Trypanosoma brucei. The screens identified compounds that were effective against the enzymes and the parasites but also some compounds that were parasiticidal despite a lack of activity against the proteases. Several compounds were effective in killing all tested parasites. These promising lead compounds were tested for general toxicity in mice, and only one produced observable toxicity after 62 h. Our results suggest that thiosemicarbazones represent validated drug leads that kill several species of protozoan parasites through the inhibition of cysteine proteases as well as other novel targets.
ANTI-PARASITIC COMPOUNDS AND METHODS OF THEIR USE
-
Page/Page column 29-30; 42, (2008/06/13)
The present invention provides a novel class of compounds that disrupt the parasitic infectious life cycle and serve as promising agents for anti-parasitic therapy.
